Cite
HARVARD Citation
Ebens, C. et al. (2019). Bone marrow transplant with post‐transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts. British journal of dermatology. pp. 1238-1246. [Online].